Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma

The prognosis of metastatic melanoma (MM) patients has remained poor for a long time. However, the recent introduction of effective target therapies (BRAF and MEK inhibitors for BRAFV600-mutated MM) and immunotherapies (anti-CTLA-4 and anti-PD-1) has significantly improved the survival of MM patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Monti, Matilde, Consoli, Francesca, Vescovi, Raffaella, Bugatti, Mattia, Vermi, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072514/
https://www.ncbi.nlm.nih.gov/pubmed/32054102
http://dx.doi.org/10.3390/cells9020417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072514/
https://www.ncbi.nlm.nih.gov/pubmed/32054102
http://dx.doi.org/10.3390/cells9020417

Ejemplares similares